Mar 012011
 

Tashkin et al randomized 504 patients at 27 centers with COPD and FEV1 > 49% to varenicline or placebo for 12 weeks, with 52 weeks follow up. Smoking cessation / abstinence rate (carbon monoxide-confirmed) was 42% vs 9% in weeks 9 - 12 (1' endpoint), and 19% vs. 6% in weeks 9 - 52 (p<0.0001). And even better, no one killed themselves! (n=504). CHEST 2011;139:591-599.

Get our weekly email update, and explore our library of practice updates and review articles.

PulmCCM is an independent publication not affiliated with or endorsed by any organization, society or journal referenced on the website. (Terms of Use | Privacy Policy)

0 Comments

Chantix worked in people with mild to moderate COPD